Copyright Reports & Markets. All rights reserved.

Global Tissue Mass Spectrometry Imaging System Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Tissue Mass Spectrometry Imaging System Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Detection Channel Is Less Than 100
    • 1.3.3 Detection Channel Is Greater Than 100
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Tissue Mass Spectrometry Imaging System Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Neuroscience
    • 1.4.3 Pathology
    • 1.4.4 Nutrition
    • 1.4.5 Others
  • 1.5 Global Tissue Mass Spectrometry Imaging System Market Size & Forecast
    • 1.5.1 Global Tissue Mass Spectrometry Imaging System Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Tissue Mass Spectrometry Imaging System Sales Quantity (2021-2032)
    • 1.5.3 Global Tissue Mass Spectrometry Imaging System Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Standard BioTools
    • 2.1.1 Standard BioTools Details
    • 2.1.2 Standard BioTools Major Business
    • 2.1.3 Standard BioTools Tissue Mass Spectrometry Imaging System Product and Services
    • 2.1.4 Standard BioTools Tissue Mass Spectrometry Imaging System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Standard BioTools Recent Developments/Updates
  • 2.2 Waters Corporation
    • 2.2.1 Waters Corporation Details
    • 2.2.2 Waters Corporation Major Business
    • 2.2.3 Waters Corporation Tissue Mass Spectrometry Imaging System Product and Services
    • 2.2.4 Waters Corporation Tissue Mass Spectrometry Imaging System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Waters Corporation Recent Developments/Updates
  • 2.3 Ionpath
    • 2.3.1 Ionpath Details
    • 2.3.2 Ionpath Major Business
    • 2.3.3 Ionpath Tissue Mass Spectrometry Imaging System Product and Services
    • 2.3.4 Ionpath Tissue Mass Spectrometry Imaging System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Ionpath Recent Developments/Updates
  • 2.4 JEOL
    • 2.4.1 JEOL Details
    • 2.4.2 JEOL Major Business
    • 2.4.3 JEOL Tissue Mass Spectrometry Imaging System Product and Services
    • 2.4.4 JEOL Tissue Mass Spectrometry Imaging System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 JEOL Recent Developments/Updates
  • 2.5 SHIMADZU
    • 2.5.1 SHIMADZU Details
    • 2.5.2 SHIMADZU Major Business
    • 2.5.3 SHIMADZU Tissue Mass Spectrometry Imaging System Product and Services
    • 2.5.4 SHIMADZU Tissue Mass Spectrometry Imaging System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 SHIMADZU Recent Developments/Updates
  • 2.6 TransMIT GmbH
    • 2.6.1 TransMIT GmbH Details
    • 2.6.2 TransMIT GmbH Major Business
    • 2.6.3 TransMIT GmbH Tissue Mass Spectrometry Imaging System Product and Services
    • 2.6.4 TransMIT GmbH Tissue Mass Spectrometry Imaging System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 TransMIT GmbH Recent Developments/Updates
  • 2.7 Thermo Fisher Scientific
    • 2.7.1 Thermo Fisher Scientific Details
    • 2.7.2 Thermo Fisher Scientific Major Business
    • 2.7.3 Thermo Fisher Scientific Tissue Mass Spectrometry Imaging System Product and Services
    • 2.7.4 Thermo Fisher Scientific Tissue Mass Spectrometry Imaging System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.8 Impact Scientific Instrument
    • 2.8.1 Impact Scientific Instrument Details
    • 2.8.2 Impact Scientific Instrument Major Business
    • 2.8.3 Impact Scientific Instrument Tissue Mass Spectrometry Imaging System Product and Services
    • 2.8.4 Impact Scientific Instrument Tissue Mass Spectrometry Imaging System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Impact Scientific Instrument Recent Developments/Updates
  • 2.9 mProbe
    • 2.9.1 mProbe Details
    • 2.9.2 mProbe Major Business
    • 2.9.3 mProbe Tissue Mass Spectrometry Imaging System Product and Services
    • 2.9.4 mProbe Tissue Mass Spectrometry Imaging System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 mProbe Recent Developments/Updates

3 Competitive Environment: Tissue Mass Spectrometry Imaging System by Manufacturer

  • 3.1 Global Tissue Mass Spectrometry Imaging System Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Tissue Mass Spectrometry Imaging System Revenue by Manufacturer (2021-2026)
  • 3.3 Global Tissue Mass Spectrometry Imaging System Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Tissue Mass Spectrometry Imaging System by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Tissue Mass Spectrometry Imaging System Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Tissue Mass Spectrometry Imaging System Manufacturer Market Share in 2025
  • 3.5 Tissue Mass Spectrometry Imaging System Market: Overall Company Footprint Analysis
    • 3.5.1 Tissue Mass Spectrometry Imaging System Market: Region Footprint
    • 3.5.2 Tissue Mass Spectrometry Imaging System Market: Company Product Type Footprint
    • 3.5.3 Tissue Mass Spectrometry Imaging System Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Tissue Mass Spectrometry Imaging System Market Size by Region
    • 4.1.1 Global Tissue Mass Spectrometry Imaging System Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Tissue Mass Spectrometry Imaging System Consumption Value by Region (2021-2032)
    • 4.1.3 Global Tissue Mass Spectrometry Imaging System Average Price by Region (2021-2032)
  • 4.2 North America Tissue Mass Spectrometry Imaging System Consumption Value (2021-2032)
  • 4.3 Europe Tissue Mass Spectrometry Imaging System Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Tissue Mass Spectrometry Imaging System Consumption Value (2021-2032)
  • 4.5 South America Tissue Mass Spectrometry Imaging System Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Tissue Mass Spectrometry Imaging System Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Tissue Mass Spectrometry Imaging System Sales Quantity by Type (2021-2032)
  • 5.2 Global Tissue Mass Spectrometry Imaging System Consumption Value by Type (2021-2032)
  • 5.3 Global Tissue Mass Spectrometry Imaging System Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Tissue Mass Spectrometry Imaging System Sales Quantity by Application (2021-2032)
  • 6.2 Global Tissue Mass Spectrometry Imaging System Consumption Value by Application (2021-2032)
  • 6.3 Global Tissue Mass Spectrometry Imaging System Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Tissue Mass Spectrometry Imaging System Sales Quantity by Type (2021-2032)
  • 7.2 North America Tissue Mass Spectrometry Imaging System Sales Quantity by Application (2021-2032)
  • 7.3 North America Tissue Mass Spectrometry Imaging System Market Size by Country
    • 7.3.1 North America Tissue Mass Spectrometry Imaging System Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Tissue Mass Spectrometry Imaging System Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Tissue Mass Spectrometry Imaging System Sales Quantity by Type (2021-2032)
  • 8.2 Europe Tissue Mass Spectrometry Imaging System Sales Quantity by Application (2021-2032)
  • 8.3 Europe Tissue Mass Spectrometry Imaging System Market Size by Country
    • 8.3.1 Europe Tissue Mass Spectrometry Imaging System Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Tissue Mass Spectrometry Imaging System Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Tissue Mass Spectrometry Imaging System Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Tissue Mass Spectrometry Imaging System Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Tissue Mass Spectrometry Imaging System Market Size by Region
    • 9.3.1 Asia-Pacific Tissue Mass Spectrometry Imaging System Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Tissue Mass Spectrometry Imaging System Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Tissue Mass Spectrometry Imaging System Sales Quantity by Type (2021-2032)
  • 10.2 South America Tissue Mass Spectrometry Imaging System Sales Quantity by Application (2021-2032)
  • 10.3 South America Tissue Mass Spectrometry Imaging System Market Size by Country
    • 10.3.1 South America Tissue Mass Spectrometry Imaging System Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Tissue Mass Spectrometry Imaging System Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Tissue Mass Spectrometry Imaging System Market Size by Country
    • 11.3.1 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Tissue Mass Spectrometry Imaging System Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Tissue Mass Spectrometry Imaging System Market Drivers
  • 12.2 Tissue Mass Spectrometry Imaging System Market Restraints
  • 12.3 Tissue Mass Spectrometry Imaging System Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Tissue Mass Spectrometry Imaging System and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Tissue Mass Spectrometry Imaging System
  • 13.3 Tissue Mass Spectrometry Imaging System Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Tissue Mass Spectrometry Imaging System Typical Distributors
  • 14.3 Tissue Mass Spectrometry Imaging System Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Tissue Mass Spectrometry Imaging System market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Mass spectrometry imaging is an imaging method based on mass spectrometry technology. This method directly scans biological samples for imaging through mass spectrometry, and can simultaneously analyze the spatial distribution characteristics of hundreds of molecules on the same tissue slice or tissue chip. In simple terms, mass spectrometry imaging technology is a method of imaging with the help of mass spectrometry, coupled with the control of specialized mass spectrometry imaging software, using a mass spectrometer that analyzes the standard molecular weight of biomolecules by determining the mass-to-charge ratio. The tissue mass spectrometry imaging system has both high-parameter single-cell suspension detection functions and tissue imaging functions. Maximize the advantages of mass spectrometry flow cytometry (CyTOF) ultra-high number of detection channels in tissue imaging research, and its performance far exceeds traditional immunohistochemistry or immunofluorescence techniques.
    This report is a detailed and comprehensive analysis for global Tissue Mass Spectrometry Imaging System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Tissue Mass Spectrometry Imaging System market size and forecasts, in consumption value ($ Million), sales quantity (Unit), and average selling prices (US$/Unit), 2021-2032
    Global Tissue Mass Spectrometry Imaging System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Unit), and average selling prices (US$/Unit), 2021-2032
    Global Tissue Mass Spectrometry Imaging System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Unit), and average selling prices (US$/Unit), 2021-2032
    Global Tissue Mass Spectrometry Imaging System market shares of main players, shipments in revenue ($ Million), sales quantity (Unit), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Tissue Mass Spectrometry Imaging System
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Tissue Mass Spectrometry Imaging System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Standard BioTools, Waters Corporation, Ionpath, JEOL, SHIMADZU, TransMIT GmbH, Thermo Fisher Scientific, Impact Scientific Instrument, mProbe, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Tissue Mass Spectrometry Imaging System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Detection Channel Is Less Than 100
    Detection Channel Is Greater Than 100
    Market segment by Application
    Neuroscience
    Pathology
    Nutrition
    Others
    Major players covered
    Standard BioTools
    Waters Corporation
    Ionpath
    JEOL
    SHIMADZU
    TransMIT GmbH
    Thermo Fisher Scientific
    Impact Scientific Instrument
    mProbe
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Tissue Mass Spectrometry Imaging System product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Tissue Mass Spectrometry Imaging System, with price, sales quantity, revenue, and global market share of Tissue Mass Spectrometry Imaging System from 2021 to 2026.
    Chapter 3, the Tissue Mass Spectrometry Imaging System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Tissue Mass Spectrometry Imaging System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Tissue Mass Spectrometry Imaging System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Tissue Mass Spectrometry Imaging System.
    Chapter 14 and 15, to describe Tissue Mass Spectrometry Imaging System sales channel, distributors, customers, research findings and conclusion.

    Buy now